CANTARGIA AB
Biotechnology · Healthcare
CFO
3 appearances
Latest appearance 2026-08-19
CFO
CANTARGIA AB
Equibles does not estimate personal net worth.
Patrick Renblad is recorded as CFO at CANTARGIA AB. Patrick Renblad has spoken on 3 earnings calls across 1 company, most recently for CANTARGIA AB on August 19, 2026. CANTARGIA AB is classified in the Biotechnology industry within the Healthcare sector.
“We are, as I mentioned, in a in a period now where we are ramping up preparations for the combination study in with Derek Sondrasib.”
“So, in Q1, 2026, we reported modest revenues of half a million Swedish kronor, all derived from the work services provided to Etsuka in relation to the can 10 transaction while our operating expenses were 37.4 million Swedish and you can see here on this slide ultimately we reported a loss in the period of 33 million…”
“So we explore all the options we can to fund the Pivotal program. Partnering is part of that. And as you alluded to, also specialist investors.”
CANTARGIA AB
CFO
Transcript header (unverified)
CANTARGIA AB
Biotechnology · Healthcare
CFO
Q2 Report 2026
CANTARGIA AB
Q1 Report 2026
CANTARGIA AB
Q4 Report 2025
CANTARGIA AB